EQIIX Performance — Allspring Emerging Markets Equity Advantage Fund, Institutional Class
Data updated: 2026-09-23
EQIIX returned +19.97% year to date and +37.38% over one year to Jul 2026. Annualised returns are +19.66% over 3 years and +16.18% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $171, against $164 for the category, and to $137 over one year, against $134. Volatility over the past three years was 16.84% a year. In the 12 months to Jul 2026 the fund lost a net $76.5M, and assets reached $411.65M.
EQIIX Growth of $100
What $100 invested in Allspring Emerging Markets Equity Advantage Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | EQIIX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $137 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $171 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $212 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $212 | $188 |
EQIIX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +19.97% |
| 1 year | +37.38% |
| 3 years (annualised) | +19.66% |
| 5 years (annualised) | +16.18% |
EQIIX Annual Returns
Calendar-year total returns of Allspring Emerging Markets Equity Advantage Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +19.97% |
| 2025 | +28.15% |
| 2024 | +10.95% |
| 2023 | +12.25% |
| 2022 | +10.56% |
| 2021 | +0.04% |
| 2020 | +0.12% |
| 2019 (Aug–Dec) | +0.10% |
EQIIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +10.0% | +6.4% | −11.2% | +13.2% | +8.8% | −2.8% | −3.6% | — | — | — | — | — |
| 2025 | 0.0% | +0.6% | +0.5% | +0.6% | +3.6% | +4.9% | +1.1% | +2.1% | +7.6% | +3.6% | −2.2% | +2.8% |
| 2024 | −1.8% | +4.9% | +2.1% | +1.0% | +2.1% | +3.3% | +0.7% | +1.1% | +5.5% | −5.1% | −2.8% | +0.1% |
| 2023 | +8.9% | −6.1% | +2.8% | −0.3% | −2.6% | +4.5% | +4.8% | −6.3% | −1.9% | −3.4% | +7.8% | +5.0% |
| 2022 | 0.0% | 0.0% | 0.0% | −0.1% | 0.0% | −0.1% | 0.0% | 0.0% | −0.1% | 0.0% | +13.7% | −2.5% |
| 2021 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2020 | −0.1% | 0.0% | −0.2% | +0.1% | 0.0% | 0.0% | +0.1% | 0.0% | 0.0% | 0.0% | +0.1% | +0.1% |
| 2019 | — | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% |
EQIIX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 16.84%
- 3-year Sharpe ratio: 0.90 (vs 4.5% risk-free rate)
- Best month: +13.18% (Apr 2026)
- Worst month: −11.19% (Mar 2026)
EQIIX Fund Flows
Monthly money in and out of Allspring Emerging Markets Equity Advantage Fund, from SEC Form N-PORT.
- 12-month net flow: −$76.5M
- 12-month gross sales (incl. reinvestments): $61.5M
- Sales ÷ redemptions: 0.45×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.7M | $30.1M | −$25.4M |
| Jun 2026 | $3.1M | $3.4M | −$310K |
| May 2026 | $9.6M | $30.9M | −$21.3M |
| Apr 2026 | $2.6M | $4.1M | −$1.4M |
| Mar 2026 | $9.2M | $9.2M | $37K |
| Feb 2026 | $4.0M | $11.1M | −$7.1M |
| Jan 2026 | $9.9M | $11.5M | −$1.5M |
| Dec 2025 | $6.9M | $3.2M | $3.7M |
| Nov 2025 | $5.9M | $11.8M | −$5.9M |
| Oct 2025 | $1.5M | $4.2M | −$2.7M |
| Sep 2025 | $2.3M | $15.6M | −$13.3M |
| Aug 2025 | $1.6M | $3.1M | −$1.4M |
EQIIX Assets Under Management
Net assets of Allspring Emerging Markets Equity Advantage Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $411.65M |
| 2026-04-30 | $453.15M |
| 2026-01-31 | $431.70M |
| 2025-10-31 | $400.86M |
| 2025-07-31 | $369.16M |
| 2025-04-30 | $346.45M |
| 2025-01-31 | $351.37M |
| 2024-10-31 | $366.71M |
| 2024-07-31 | $372.92M |
| 2024-04-30 | $357.28M |
| 2024-01-31 | $325.80M |
| 2023-10-31 | $290.23M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.